Abingdon is a Drug Development Management Organization (DDMO) offering technical and operational expertise in all aspects of drug development from strategic assistance with candidate selection through pre-clinical and clinical portfolio development incorporating guidance on the strategy and minimum requirements for new drug applications including ANDAs and 505(b)2 applications.